{"title":"通过多普勒超声评估肾移植功能障碍:系统回顾和荟萃分析。","authors":"Shirin Habibi, Seyed Morteza Bagheri, Mostafa Ghadamzadeh, Seyed Reza Saadat Mostafavi, Adeleh Dadkhah","doi":"10.22088/cjim.15.3.374","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Doppler sonography parameters, particularly the resistive index (RI), have been identified as an essential tool for assessing renal transplant dysfunction (RTD). However, there is some ambiguity in the findings of previous research studies on this matter. Therefore, the objective of our study is to examine the relationship between changes in RI subsequent to RTD.</p><p><strong>Methods: </strong>This was a systematic review and meta-analysis study. We searched three electronic databases PubMed, Web of Science, and Scopus, from the year 2000 to 10 May 2022. The main effect size was considered as the mean RI differences of cases with RTD confirmed by biopsy with control patients with no RTD. We used random effect models to pool the effect size.</p><p><strong>Results: </strong>Thirteen studies were included in our review. The pooled mean (95% CI) for the control group was calculated to be 0.71 (0.67, 0.75) and for patients with renal transplant dysfunction was 0.73 (0.68, 0.78), under a random effect model with high heterogeneity for both analyses (I<sup>2</sup>=98% and 97%, respectively). The pooled mean was significantly different between the control group and patients with RTD (P= 0.05), based on a t-test of pooled effect sizes.</p><p><strong>Conclusions: </strong>Based on the result of our study, we showed that there is a significant difference between RI in patients with kidney transplant dysfunction and the control group. However, RI cannot substitute kidney biopsy in the management and diagnosis of RTD.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246670/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessment of renal transplant dysfunction by doppler sonography: A systematic review and meta-analysis.\",\"authors\":\"Shirin Habibi, Seyed Morteza Bagheri, Mostafa Ghadamzadeh, Seyed Reza Saadat Mostafavi, Adeleh Dadkhah\",\"doi\":\"10.22088/cjim.15.3.374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Doppler sonography parameters, particularly the resistive index (RI), have been identified as an essential tool for assessing renal transplant dysfunction (RTD). However, there is some ambiguity in the findings of previous research studies on this matter. Therefore, the objective of our study is to examine the relationship between changes in RI subsequent to RTD.</p><p><strong>Methods: </strong>This was a systematic review and meta-analysis study. We searched three electronic databases PubMed, Web of Science, and Scopus, from the year 2000 to 10 May 2022. The main effect size was considered as the mean RI differences of cases with RTD confirmed by biopsy with control patients with no RTD. We used random effect models to pool the effect size.</p><p><strong>Results: </strong>Thirteen studies were included in our review. The pooled mean (95% CI) for the control group was calculated to be 0.71 (0.67, 0.75) and for patients with renal transplant dysfunction was 0.73 (0.68, 0.78), under a random effect model with high heterogeneity for both analyses (I<sup>2</sup>=98% and 97%, respectively). The pooled mean was significantly different between the control group and patients with RTD (P= 0.05), based on a t-test of pooled effect sizes.</p><p><strong>Conclusions: </strong>Based on the result of our study, we showed that there is a significant difference between RI in patients with kidney transplant dysfunction and the control group. However, RI cannot substitute kidney biopsy in the management and diagnosis of RTD.</p>\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246670/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22088/cjim.15.3.374\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22088/cjim.15.3.374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:多普勒超声参数,尤其是阻力指数(RI),已被确定为评估肾移植功能障碍(RTD)的重要工具。然而,以往的相关研究结果存在一定的模糊性。因此,我们的研究旨在探讨 RI 变化与 RTD 之间的关系:这是一项系统回顾和荟萃分析研究。我们检索了从 2000 年到 2022 年 5 月 10 日的 PubMed、Web of Science 和 Scopus 三个电子数据库。主效应大小是指经活检证实有RTD的病例与无RTD的对照组患者的平均RI差异。我们使用随机效应模型来汇集效应大小:我们的研究共纳入了 13 项研究。在随机效应模型下,计算出对照组的汇集平均值(95% CI)为 0.71(0.67,0.75),肾移植功能障碍患者的汇集平均值为 0.73(0.68,0.78),两项分析的异质性都很高(I2=98%,97%)。根据集合效应大小的t检验,对照组和RTD患者的集合平均值有明显差异(P= 0.05):根据我们的研究结果,我们发现肾移植功能障碍患者的 RI 与对照组存在明显差异。然而,在 RTD 的管理和诊断中,RI 无法替代肾活检。
Assessment of renal transplant dysfunction by doppler sonography: A systematic review and meta-analysis.
Background: Doppler sonography parameters, particularly the resistive index (RI), have been identified as an essential tool for assessing renal transplant dysfunction (RTD). However, there is some ambiguity in the findings of previous research studies on this matter. Therefore, the objective of our study is to examine the relationship between changes in RI subsequent to RTD.
Methods: This was a systematic review and meta-analysis study. We searched three electronic databases PubMed, Web of Science, and Scopus, from the year 2000 to 10 May 2022. The main effect size was considered as the mean RI differences of cases with RTD confirmed by biopsy with control patients with no RTD. We used random effect models to pool the effect size.
Results: Thirteen studies were included in our review. The pooled mean (95% CI) for the control group was calculated to be 0.71 (0.67, 0.75) and for patients with renal transplant dysfunction was 0.73 (0.68, 0.78), under a random effect model with high heterogeneity for both analyses (I2=98% and 97%, respectively). The pooled mean was significantly different between the control group and patients with RTD (P= 0.05), based on a t-test of pooled effect sizes.
Conclusions: Based on the result of our study, we showed that there is a significant difference between RI in patients with kidney transplant dysfunction and the control group. However, RI cannot substitute kidney biopsy in the management and diagnosis of RTD.